Obermatt
See Similar Stocks →

DiaMedica Therapeutics

NAQ:DMAC · CA25253X2077
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings67
Price/Book1
Dividend Yield—
Revenue Growth—
Profit Growth93
Capital Growth36
TSR 52w55
Leverage89
Liquidity49
Refinancing50
Combined—
Analyst Opinions100
Pro Holdings25
Opinion Changes50
Market Pulse22

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2000
Employees35
Websitediamedica.com
ISINCA25253X2077
Last UpdateApr 2, 2026
Index & Theme
CardiovascularInflammationNephrologyNeurologyBiopharmaBiotechnologyTherapeutics

Description

DiaMedica Therapeutics Inc. operates as a clinical-stage biopharmaceutical company. The company is committed to improving the lives of people suffering from severe ischemic disease, with two main clinical programs focused on preeclampsia (PE) / feta…

Similar Stocks

The companies this stock is ranked against.

Compare DiaMedica Therapeutics with its peers
Kymera Therapeutics
NMQ:KYMR
30
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Disc Medicine
NMQ:IRON
5
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Agios Pharmaceuticals
NSQ:AGIO
30
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Kodiak Sciences
NMQ:KOD
82
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
AVITA Medical
NAQ:RCEL
31
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Scholar Rock
NSQ:SRRK
67
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →